Sanofi ADR
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $10,735,000 | $10,606,000 | $7,631,000 | $14,157,000 |
Gross Profit | 7,743,000 | 7,717,000 | 5,360,000 | 10,072,000 |
EBITDA | 1,889,000 | 2,770,000 | 563,000 | 4,247,000 |
EBIT | 1,511,000 | 2,371,000 | 354,000 | 3,768,000 |
Net Income | 3,940,000 | 1,872,000 | 499,000 | 2,815,000 |
Net Change In Cash | 10,735,000 | 10,606,000 | 7,631,000 | 14,157,000 |
Free Cash Flow | 42,000 | 2,093,000 | ||
Cash | 15,359,000 | 7,991,000 | 7,441,000 | |
Basic Shares | 2,467,800 | 2,467,800 | 2,507,200 | 2,506,000 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $44,286,000 | $46,033,000 | $40,304,000 | $39,175,000 |
Gross Profit | 31,081,000 | 31,797,000 | 28,679,000 | 26,920,000 |
EBITDA | 11,033,000 | 11,997,000 | 13,510,000 | 11,291,000 |
EBIT | 7,447,000 | 8,221,000 | 10,402,000 | 8,160,000 |
Net Income | 5,560,000 | 5,400,000 | 8,371,000 | 6,223,000 |
Net Change In Cash | 44,286,000 | 46,033,000 | 40,304,000 | 39,175,000 |
Free Cash Flow | 5,886,000 | 8,639,000 | 8,325,000 | 8,479,000 |
Cash | 7,441,000 | 8,710,000 | 12,736,000 | 10,098,000 |
Basic Shares | 2,502,800 | 2,512,800 | 2,503,800 | 2,505,000 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | $0.91 |
2025-03-31 | $1.02 |
2024-12-31 | $0.68 |
2024-09-30 | $1.54 |
